65 studies found for:
Open Studies | "Unrelated Donors"
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Unrelated Donor Stem Cell Transplantation
|
||||
2 | Recruiting |
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
|
||||
3 | Recruiting |
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
|
||||
4 | Recruiting |
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
|
||||
5 | Recruiting |
Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors
|
||||
6 | Not yet recruiting |
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma
|
||||
7 | Recruiting |
A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias
|
||||
8 | Recruiting |
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
|
||||
9 | Recruiting |
Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
|
||||
10 | Recruiting |
Unrelated Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
|
||||
11 | Recruiting |
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
|
||||
12 | Recruiting |
A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
|
||||
13 | Recruiting |
Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)
|
||||
14 | Unknown † |
Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
|
||||
15 | Recruiting |
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
|
||||
16 | Recruiting |
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
|
||||
17 | Recruiting |
Myeloablative Unrelated Donor Double-Unit Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies
|
||||
18 | Unknown † |
Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation
|
||||
19 | Unknown † |
Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant
|
||||
20 | Recruiting |
Selecting a Favorable KIR Donor in Unrelated HCT for AML
|
† Indicates status has not been verified in more than two years